Publications indexed to the term Huntington Disease
| Faculty | Title |
|---|---|
| 1 | Molecular insights into cortico-striatal miscommunications in Huntington's disease. (Veldman MB, Yang XW) Curr Opin Neurobiol 2018 Feb;48:79-89 41 Citations |
| 1 | Huntington's Disease: Nuclear Gatekeepers Under Attack. (Veldman MB, Yang XW) Neuron 2017 Apr 05;94(1):1-4 9 Citations |
| 1 | Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial. (Huntington Study Group, Frank S, Testa CM, Stamler D, Kayson E, Davis C, Edmondson MC, Kinel S, Leavitt B, Oakes D, O'Neill C, Vaughan C, Goldstein J, Herzog M, Snively V, Whaley J, Wong C, Suter G, Jankovic J, Jimenez-Shahed J, Hunter C, Claassen DO, Roman OC, Sung V, Smith J, Janicki S, Clouse R, Saint-Hilaire M, Hohler A, Turpin D, James RC, Rodriguez R, Rizer K, Anderson KE, Heller H, Carlson A, Criswell S, Racette BA, Revilla FJ, Nucifora F Jr, Margolis RL, Ong M, Mendis T, Mendis N, Singer C, Quesada M, Paulsen JS, Brashers-Krug T, Miller A, Kerr J, Dubinsky RM, Gray C, Factor SA, Sperin E, Molho E, Eglow M, Evans S, Kumar R, Reeves C, Samii A, Chouinard S, Beland M, Scott BL, Hickey PT, Esmail S, Fung WL, Gibbons C, Qi L, Colcher A, Hackmyer C, McGarry A, Klos K, Gudesblatt M, Fafard L, Graffitti L, Schneider DP, Dhall R, Wojcieszek JM, LaFaver K, Duker A, Neefus E, Wilson-Perez H, Shprecher D, Wall P, Blindauer KA, Wheeler L, Boyd JT, Houston E, Farbman ES, Agarwal P, Eberly SW, Watts A, Tariot PN, Feigin A, Evans S, Beck C, Orme C, Edicola J, Christopher E) JAMA 2016 Jul 05;316(1):40-50 195 Citations |
| 1 | The N17 domain mitigates nuclear toxicity in a novel zebrafish Huntington's disease model. (Veldman MB, Rios-Galdamez Y, Lu XH, Gu X, Qin W, Li S, Yang XW, Lin S) Mol Neurodegener 2015 Dec 09;10:67 39 Citations |
| 1 | Symptom validity test performance in the Huntington Disease Clinic. (Sieck BC, Smith MM, Duff K, Paulsen JS, Beglinger LJ) Arch Clin Neuropsychol 2013 Mar;28(2):135-43 17 Citations |
| 1 | Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes. (HD iPSC Consortium) Cell Stem Cell 2012 Aug 03;11(2):264-78 412 Citations |
| 1 | Ex vivo delivery of GDNF maintains motor function and prevents neuronal loss in a transgenic mouse model of Huntington's disease. (Ebert AD, Barber AE, Heins BM, Svendsen CN) Exp Neurol 2010 Jul;224(1):155-62 74 Citations |
| 1 | Suppression of Huntington's disease pathology in Drosophila by human single-chain Fv antibodies. (Wolfgang WJ, Miller TW, Webster JM, Huston JS, Thompson LM, Marsh JL, Messer A) Proc Natl Acad Sci U S A 2005 Aug 09;102(32):11563-8 133 Citations |
| 1 | Intrabody applications in neurological disorders: progress and future prospects. (Miller TW, Messer A) Mol Ther 2005 Sep;12(3):394-401 75 Citations |
| 1 | A human single-chain Fv intrabody preferentially targets amino-terminal Huntingtin's fragments in striatal models of Huntington's disease. (Miller TW, Zhou C, Gines S, MacDonald ME, Mazarakis ND, Bates GP, Huston JS, Messer A) Neurobiol Dis 2005;19(1-2):47-56 52 Citations |
| 1 | DNA vaccination against mutant huntingtin ameliorates the HDR6/2 diabetic phenotype. (Miller TW, Shirley TL, Wolfgang WJ, Kang X, Messer A) Mol Ther 2003 May;7(5 Pt 1):572-9 57 Citations |
| 1 | Single photon emission computerized tomography (SPECT) in detecting neurodegeneration in Huntington's disease. (Reynolds NC Jr, Hellman RS, Tikofsky RS, Prost RW, Mark LP, Elejalde BR, Lebel R, Hamsher KS, Swanson S, Benezra EE) Nucl Med Commun 2002 Jan;23(1):13-8 11 Citations |
